Exposure to alcohol during adolescence exerts long-term effects on stress response and the adult brain stress circuits.
The hypothalamic-pituitary-adrenal (HPA) axis undergoes critical developments during adolescence. Therefore, stressors experienced during this period potentially have long-term effects on adult HPA axis function. We hypothesized that adolescent intermittent ethanol (AIE) exposure would affect adult HPA axis function, resulting in altered responses to an alcohol challenge in young adults or adults. To test these hypotheses, male rats were exposed to alcohol vapor for 6h per day from post-natal day (PND) 28-42, then acutely challenged with alcohol intragastrically (3.2-4.5g/kg) in young adults (PND 70) or adults (PND 90). Overall, we observed blunted HPA axis responses to an alcohol challenge due to AIE exposure. Specifically, AIE tended to inhibit the alcohol challenge-induced increase in plasma corticosterone (CORT) concentrations in young adult and adult rats. As well, AIE significantly blunted the alcohol challenge-induced arginine vasopressin (Avp) mRNA expression in the paraventricular nucleus (PVN) of the hypothalamus of adult rats. Results of the present study are similar to what we have previously shown, that these changes in PVN responsiveness may result from AIE-induced alterations in adrenergic neurons in brain stem regions C1-C3 known to project to the PVN. AIE elevated the number of colocalized c-fos/phenylethanolamine N-methyltransferase (PNMT)-positive cell bodies in the C1 region of adult rats. Together, these data suggest that AIE exposure produces alterations in male HPA axis responsiveness to administration of an acute alcohol challenge that may be long-lasting.
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA.
Camryn D
CD
Allen
Laboratory of Neuronal Structure and Function, The Salk Institute, La Jolla, CA 92037, USA.
Jan-Sebastian
JS
Grigoleit
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA.
Joonho
J
Hong
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA.
Sejin
S
Bae
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA.
Joan
J
Vaughan
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA. Electronic address: slee@salk.edu.
Soon
S
Lee
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000254:growth & development* / Q000378:metabolism; D002492:Central Nervous System Depressants / Q000097:blood / Q000633:toxicity*; D003345:Corticosterone / Q000097:blood; D004195:Disease Models, Animal; D000431:Ethanol / Q000097:blood / Q000633:toxicity*; D008297:Male; D010625:Phenylethanolamine N-Methyltransferase / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D017207:Rats, Sprague-Dawley; D013315:Stress, Psychological / Q000378:metabolism*
D002492:Central Nervous System Depressants; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D001127:Arginine Vasopressin; D000431:Ethanol; D010625:Phenylethanolamine N-Methyltransferase; D003345:Corticosterone
Avp; Crf; PNMT; alcohol; corticosterone
Physiol Res. 2011;60 Suppl 1:S171-6
21777029
Alcohol Clin Exp Res. 2003 Sep;27(9):1463-70
14506408
Alcohol Clin Exp Res. 2003 Jun;27(6):989-96
12824821
PLoS One. 2011 Apr 13;6(4):e18350
21533237
Pharmacol Biochem Behav. 2007 Feb;86(2):320-6
17098280
Alcohol Clin Exp Res. 2001 Jan;25(1):98-105
11198721
J Neurosci. 1995 Aug;15(8):5439-47
7643193
Psychol Bull. 2004 Jul;130(4):601-30
15250815
Alcohol Clin Exp Res. 1997 May;21(3):467-76
9161607
Neuroscience. 2008 Aug 26;155(3):888-901
18588946
J Exp Biol. 2013 Jun 15;216(Pt 12):2302-7
23580725
Brain Res. 1990 Jun 18;520(1-2):1-5
2169950
J Neurochem. 2009 Feb;108(4):920-31
19077056
Dev Psychobiol. 2010 Apr;52(3):236-43
20222058
Mol Cell Neurosci. 2000 Oct;16(4):515-28
11085885
Brain Behav Immun. 2011 Jun;25 Suppl 1:S50-60
21300146
Alcohol Clin Exp Res. 2000 Jan;24(1):110-22
10656200
Alcohol Clin Exp Res. 2005 Jul;29(7):1139-45
16046868
Neuroscience. 2011 May 19;182:162-8
21382450
Neuroscience. 2013 Apr 3;235:174-86
23337533
Eur J Neurosci. 2008 Oct;28(8):1641-53
18979677
Alcohol Clin Exp Res. 2000 Nov;24(11):1712-23
11104119
Hippocampus. 2010 May;20(5):596-607
19554644
J Pharmacol Exp Ther. 1984 Apr;229(1):127-31
6323684